The Silvacx Team is a well balanced mixture of industrial experience, academic know how and entrepreneuership.

Silvacx Core Team

Current team members:

  • Armin Kübelbeck, Dipl.-Ing.; Head of Silvacx Project
  • Agnieszka Grabowska, PhD; Principal Scientist; Vaccine Development
  • Armin Götzke, PhD; IP & Regulatory Affairs
  • Thomas Kessler, Dipl.-Ing. (Chemistry), Dipl.-Betriebswirt; Business Development


Silvacx's Scientific Advisory Board

  • Prof. Dr. Dirk Jäger,

    Managing Director, National Center for Tumor Diseases (NCT), Heidelberg. Head of Medical Oncology.

  • Prof. Dr. Walter Mier,
    of Radiopharmaceutical Chemistry, University Hospital Heidelberg.
    Antiinfektiva GmbH.

  • PD Dr. Dr. Angelika Riemer,

    Head of Immunotherapy andprevention, German Cancer Research Centrum (DKFZ), Heidelberg

  • Dr. Michael Wolf,

    former Head of Immunoncolgy at Merck KGaA (Darmstadt). 


Silvacx‘s Business Advisory Board

  • Dr. Jörg Fregien,

    Managing Director, Life Science Inkubator GmbH.
    board member of Bauerfeind AG and Executive Director at Biotronik GmbH.

  • Dr. Franz-Josef Placke

    Independent Life Science Consultant
    Chair of the Advisory Board of Rottendorf Pharma, Retired from Bayer, former Head of Development and Executive Committee Member of Bayer CropScience, former Head of Operations at Bayer Pharma and Animal Health.